EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vivo evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by Klebsiella pneumoniae sequence type 512

Valerio Capitani iD, Gabriele Arcari, Cecilia Ambrosi iD, Daniela Scribano iD, Mariateresa Ceparano, Riccardo Polani, Alice De Francesco, Giammarco Raponi, Giancarlo Ceccarelli, Paolo Villari, Anna Teresa Palamara, Carolina Marzuillo und 1 weitere

mSphere · 2024

DOI: 10.1128/msphere.00423-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2024. Verfasst von Valerio Capitani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Ceftazidime, Klebsiella Infections, Azabicyclo Compounds. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Sapienza Università di Roma, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenemase-producing Klebsiella pneumoniae represents a major public health issue globally. Isolates with resistance to the newest drugs, like ceftazidime/avibactam (CZA), are increasingly reported. In this study, we analyzed the evolution of KPC-3-producing sequence type (ST) 512 K . pneumoniae strains isolated at three different times (hospitalization days 45, 56, and 78) from the same patient, two of which were observed in a pericholecystic liver abscess. The three K. pneumoniae isolates (295Kp, 304Kp, and hmv-318Kp) from the same patient were subjected to antimicrobial susceptibility testing, whole-genome sequencing, sedimentation assay, biofilm measurement, serum resistance assay, macrophage phagocytosis, and adhesion assays. KPC-producing isolate hmv-318Kp exhibited carbapenem susceptibility, hypermucoviscous (hmv) colony phenotype and CZA resistance. Virulence markers of hypervirulent Klebsiella were absent. Two non-synonymous mutations were identified in the hmv-318Kp genome comparing with isogenic strains: a single-nucleotide polymorphism (SNP) occurred in the pKpQIL plasmid, changing bla KPC-3 in the bla KPC-31 gene variant, conferring CZA resistance; and a second SNP occurred in the wzc gene of the capsular biosynthesis cluster, encoding a tyrosine kinase, resulting in the F557S Wzc protein mutation. The Klebsiella pneumoniae strain exhibiting an hmv phenotype (hmv-Kp) phenotype has been previously associated with amino acid substitutions occurring in the Wzc tyrosin kinase protein. We observed in vivo evolution of the ST512 strain to CZA resistance and acquisition of hypermucoviscosity. The pathogenetic role of the detected Wzc substitution is not fully elucidated, but other Wzc mutations were previously reported in hmv K. pneumoniae . Wzc mutants may be more frequent than expected and an underreported cause of hypermucoviscosity in K. pneumoniae clinical isolates. IMPORTANCE Here we describe the evolution of KPC-3-producing ST512 K. pneumoniae isolated at three different times from the same patient of which the last one, from a biliary abscess, showed CZA resistance by KPC-31 production and manifested hmv colony phenotype. Hypervirulent Klebsiella pneumoniae (hv-Kp) isolates are increasingly reported worldwide. Their hypervirulent traits are associated with the presence of rmpA/A2 genes and an hmv. In this study, we identified an hmv-Kp that lacked the rmpA-D cluster but showed an amino acid substitution in the Wzc tyrosin kinase protein, involved in the capsular biosynthesis. This hmv-Kp strain emerged in vivo and evolved resistance to ceftazidime/avibactam resistance in a liver abscess of a patient. Our findings suggest that wzc mutations may be underreported, making it challenging to distinguish hv-Kp from “classic” K. pneumoniae with an hmv phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeCeftazidimeKlebsiella InfectionsAzabicyclo CompoundsDrug CombinationsAnti-Bacterial AgentsLiver AbscessMicrobial Sensitivity TestsHumansBacterial ProteinsWhole Genome Sequencingbeta-LactamasesDrug Resistance, Multiple, BacterialVirulenceEvolution, MolecularBiofilmsPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

KPC-31ST512antibiotic resistancecapsulehmvhypermucoidhypervirulencemucoviscousrmpA negativeserum susceptibilitystring testwzc

Substanzen

Ceftazidimeavibactam, ceftazidime drug combinationAzabicyclo CompoundsDrug CombinationsAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamases

Autor:innen und Institutionen

  • Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
  • Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Department of Promotion of Human Sciences and Quality of Life, San Raffaele University, Rome, Italy.
  • Laboratory of Microbiology of Chronic-Neurodegenerative Diseases, IRCCS San Raffaele Roma, Rome, Italy.
  • Clinical Microbiology Unit, University Hospital, Policlinico Umberto I, Rome, Italy.
  • Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

ORCID-Profile: Valerio Capitani, Cecilia Ambrosi, Daniela Scribano, Alessandra Carattoli

Förderung

  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • Sapienza Università di Roma
  • Ministero della Salute

Zitieren

APA

Capitani, V., Arcari, G., Ambrosi, C., Scribano, D., Ceparano, M., Polani, R., De Francesco, A., Raponi, G., Ceccarelli, G., Villari, P., Palamara, A. T., Marzuillo, C., & Carattoli, A. (2024). In vivo evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by Klebsiella pneumoniae sequence type 512. mSphere. https://doi.org/10.1128/msphere.00423-24

Vancouver

Capitani V, Arcari G, Ambrosi C, Scribano D, Ceparano M, Polani R, et al. In vivo evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by Klebsiella pneumoniae sequence type 512. mSphere. 2024. doi:10.1128/msphere.00423-24

BibTeX
@article{Capitani2024,
  author = {Capitani, Valerio and Arcari, Gabriele and Ambrosi, Cecilia and Scribano, Daniela and Ceparano, Mariateresa and Polani, Riccardo and De Francesco, Alice and Raponi, Giammarco and Ceccarelli, Giancarlo and Villari, Paolo and Palamara, Anna Teresa and Marzuillo, Carolina and Carattoli, Alessandra},
  title = {In vivo evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by Klebsiella pneumoniae sequence type 512},
  journal = {mSphere},
  year = {2024},
  doi = {10.1128/msphere.00423-24}
}
Kostenlos starten →